Literature DB >> 23649322

Serum biomarkers and the prognosis of AMI patients.

S Wei1, L Mao, B Liu, L Zhong.   

Abstract

BACKGROUND: It has been proven that serum lactate dehydrogenase (LDH) and total bilirubin (TB) increase during acute myocardial infarction (AMI). However, how they influence the prognosis of AMI patients is still not completely known.
METHODS: A total of 239 patients diagnosed with AMI and admitted to the Fourth Clinical Hospital of Harbin Medical University, between 2007 and 2008, were enrolled in this study. All the patients had not undergone primary percutaneous coronary intervention (PCI) because the time window (24 h) was missed. They all underwent PCI 1 week after the onset of symptoms. Serum high-sensitivity C-reactive protein (hs-CRP), TB, LDH, and other biomarkers were determined between 24 and 48 h of symptom onset. All of the patients were followed up for an average of 3.2±0.4 years for occurrence of major adverse cardiac events (MACE).
RESULTS: Patients with MACE had significantly higher levels of hs-CRP, LDH, cystatin C, uric acid, a higher ratio of LDH and TB (LDH/TB), and a lower level of TB: 8.48±3.84 vs. 2.13±1.32 μmol/l, p<0.01; 1,355.8±654.3 vs. 1,151.7±415.4 U/l, p<0.01; 1.69±0.76 vs. 1.00±0.46 mg/l, p<0.01; 419.6±109.2 vs. 343.2±108.2 μmol/l, p<0.01 and 141.1±46.2 vs. 61.2±26.5, p<0.01; 18.3±6.7 vs. 14.8±6.6 mg/l, p<0.01, respectively. In the multivariate COX analysis, LDH, cystatin C, and LDH/TB were significantly associated with the prognosis of these patients.
CONCLUSIONS: Patients under higher oxidative stress tend to have more MACE. LDH, cystatin C, and LDH/TB are strongly related to the prognosis of AMI patients undergoing elective PCI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23649322     DOI: 10.1007/s00059-013-3828-9

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  25 in total

1.  The association of serum uric acid levels with outcomes following percutaneous coronary intervention.

Authors:  Daniel B Spoon; Amir Lerman; Andrew D Rule; Abhiram Prasad; Ryan J Lennon; David R Holmes; Charanjit S Rihal
Journal:  J Interv Cardiol       Date:  2010-06       Impact factor: 2.279

2.  Plasma cystatin C concentration reflects the severity of coronary artery disease in patients without chronic kidney disease.

Authors:  Arihiro Kiyosue; Yasunobu Hirata; Jiro Ando; Hideo Fujita; Toshihiro Morita; Masao Takahashi; Daisuke Nagata; Takahide Kohro; Yasushi Imai; Ryozo Nagai
Journal:  Circ J       Date:  2010-09-29       Impact factor: 2.993

3.  Hyperbilirubinemia, augmentation of endothelial function, and decrease in oxidative stress in Gilbert syndrome.

Authors:  Tatsuya Maruhashi; Junko Soga; Noritaka Fujimura; Naomi Idei; Shinsuke Mikami; Yumiko Iwamoto; Masato Kajikawa; Takeshi Matsumoto; Yasuki Kihara; Kazuaki Chayama; Kensuke Noma; Ayumu Nakashima; Hirofumi Tomiyama; Bonpei Takase; Akira Yamashina; Yukihito Higashi
Journal:  Circulation       Date:  2012-07-06       Impact factor: 29.690

4.  Association between deteriorated renal function and long-term clinical outcomes after percutaneous coronary intervention.

Authors:  Manabu Ogita; Kenichi Sakakura; Tomohiro Nakamura; Hiroshi Funayama; Hiroshi Wada; Ryo Naito; Yoshitaka Sugawara; Norifumi Kubo; Junya Ako; Shin-ichi Momomura
Journal:  Heart Vessels       Date:  2011-08-06       Impact factor: 2.037

5.  The status of coronary artery lesions in patients with conduction disturbance.

Authors:  Shipeng Wei; Lihua Zhong; Song Chen; Xueqi Li
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2011-10       Impact factor: 2.160

6.  Cystatin C levels are associated with the prognosis of systolic heart failure patients.

Authors:  Changlu Gao; Lihua Zhong; Yanhui Gao; Xueqi Li; Mingyu Zhang; Shipeng Wei
Journal:  Arch Cardiovasc Dis       Date:  2011-10-29       Impact factor: 2.340

7.  Cystatin C associates with the prediction of in-stent restenosis among patients receiving stent implantation: results of the 1-year follow-up.

Authors:  Chunyu Zhao; Lanshu Yang; Lili Mao; Lihua Zhong; Xueqi Li; Shipeng Wei
Journal:  Coron Artery Dis       Date:  2013-08       Impact factor: 1.439

8.  Direct admission versus transfer of AMI patients for primary PCI.

Authors:  Christoph Liebetrau; Sebastian Szardien; Johannes Rixe; Mariella Woelken; Andreas Rolf; Timm Bauer; Holger Nef; Helge Möllmann; Christian Hamm; Michael Weber
Journal:  Clin Res Cardiol       Date:  2010-09-21       Impact factor: 5.460

9.  Clinical utility of serum cystatin C in predicting coronary artery disease.

Authors:  Mevlut Koc; Mustafa Kemal Batur; Osman Karaarslan; Gülcan Abali
Journal:  Cardiol J       Date:  2010       Impact factor: 2.737

10.  The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases.

Authors:  Libor Vítek
Journal:  Front Pharmacol       Date:  2012-04-03       Impact factor: 5.810

View more
  6 in total

1.  Usefulness of serum bilirubin levels as a biomarker for long-term clinical outcomes after percutaneous coronary intervention.

Authors:  Hyun-Wook Kim; Dong-Hyun Choi; Leejin Lim; Young-Min Lee; Joon Tae Kang; Seung Seok Chae; Young-Jae Ki; Heesang Song; Young-Youp Koh
Journal:  Heart Vessels       Date:  2014-07-22       Impact factor: 2.037

2.  Combined biomarker testing for the prediction of left ventricular remodelling in ST-elevation myocardial infarction.

Authors:  Sebastian Johannes Reinstadler; Hans-Josef Feistritzer; Martin Reindl; Gert Klug; Agnes Mayr; Johannes Mair; Werner Jaschke; Bernhard Metzler
Journal:  Open Heart       Date:  2016-09-20

3.  Roles of ST2, IL-33 and BNP in predicting major adverse cardiovascular events in acute myocardial infarction after percutaneous coronary intervention.

Authors:  Yan-Peng Wang; Jian-Hua Wang; Xiao-Long Wang; Jun-Yi Liu; Fang-Yun Jiang; Xiao-Li Huang; Jing-Yu Hang; Wei Qin; Shi-Xin Ma; Jie Zhang; Min-Jie Yuan; Jing-Bo Li; Zhi-Gang Lu; Meng Wei
Journal:  J Cell Mol Med       Date:  2017-06-17       Impact factor: 5.310

4.  Prognostic Value of Serum Total Bilirubin after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome.

Authors:  Chengchun Tang; Hao Qian; Dong Wang; Yong Qiao; Gaoliang Yan
Journal:  Biomed Res Int       Date:  2019-05-28       Impact factor: 3.411

5.  Prognostic value of total bilirubin in patients with acute myocardial infarction: A meta-analysis.

Authors:  Hongyou Shen; Canhui Zeng; Xiaowei Wu; Shizhao Liu; Xiaomin Chen
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

6.  Predicting value of white cell count and total bilirubin on clinical outcomes in patients with ST-elevation myocardial infarction following percutaneous coronary intervention: a cohort study.

Authors:  Munire Tuxun; Qian Zhao; Yang Xiang; Fen Liu; Chun-Fang Shan; Xin-Rong Zhou; Ning Song; Ajiguli Waisiding; Xue-He Zhang; Gulandanmu Aihemaiti; Yi-Ning Yang; Xiao-Mei Li
Journal:  BMJ Open       Date:  2020-02-18       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.